ABH Healthcare IPO
ABH Healthcare IPO is an SME IPO raising ₹35 Cr at ₹96 – ₹102 a share. It listed on 1 Sept 2026 at ₹99, −2.9% against its issue price of ₹102, and trades at ₹66 today (−35.3% since issue). It was subscribed 2.16× in total.
2.2 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
The numbers at a glance
The price they’re asking →derived: cut-off price Rs102 / stated EPS Rs7.05 (FY2026 (year ended March 31, 2026) basic and diluted EPS, restated consolidated; post-bonus). Stated figures are as printed in the prospectus; margins, growth and the borrowing ratio are computed from its own summary table. A multiple is one lens, not a verdict.
The last few years in numbers
From the prospectus’s own summary financial table (restated consolidated). Margins and growth are computed from the stated figures; everything else is as printed.
| Period | Revenue | Profit after tax | PAT margin | Net worth | Borrowings |
|---|---|---|---|---|---|
| FY2026 | ₹53 Cr+7% | ₹6 Cr+5% | 10.7% | ₹17 Cr | ₹55 Cr |
| FY2025 | ₹49 Cr+19% | ₹5 Cr+223% | 10.9% | ₹12 Cr | ₹42 Cr |
| FY2024 | ₹41 Cr | ₹2 Cr | 4.0% | ₹6 Cr | ₹36 Cr |
Where the money goes
The offer →Most of this issue is new shares — the money raised goes to the company, not to exiting shareholders.
How its cohort has done
131 SME issues listed in 2026 that we can price today. This is the group this issue belongs to.
Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →
What we hold for this issue
Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.
What could go wrong
All 14risks & documents →From the register read out of the issuer’s own prospectus — each item is quoted verbatim with its page on the risks tab.
Led by Fedex Securities Private Limited — median +12.4% across the 18 of its issues we can price. All lead managers →
What happens when
Next: the UPI mandate expires on 8 Oct 2026.
What to watch
- Priced at 14.5× earnings — 44% below the median of the peers the issuer itself names.
- The register's top risk: Title dispute on hospital Block-1 (Waqf/Central Government) (prospectus page 36).
- Its cohort's record: median +8.4% since issue price, 46.6% now below it — a base rate, not a forecast.
Each line restates a disclosure from the prospectus or the exchanges — nothing here is a recommendation to apply to this issue.
Track ABH HEALTHCARE LIMITED
Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.
Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.